Scientists examined the ability of serum albumin levels and leukocyte subtypes to predict the therapeutic efficacy of tacrolimus in patients with ulcerative colitis.
[Scientific Reports]
Home Newsletters Human Immunology News Lymphocyte to Monocyte Ratio and Serum Albumin Changes Predict Tacrolimus Therapy Outcomes...
